Mosier, D E <br/><br/>
Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Mar 1993 
 - 2443-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.90.6.2443  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Acquired Immunodeficiency Syndrome--immunology<br/>Adult<br/>Animals<br/>Cell Line<br/>Enzyme-Linked Immunosorbent Assay<br/>Gene Products, env--genetics<br/>HIV Antibodies--blood<br/>HIV Envelope Protein gp160<br/>HIV-1--immunology<br/>Humans<br/>Immunization Schedule<br/>Immunization, Secondary<br/>Immunotherapy, Adoptive<br/>Leukocyte Transfusion<br/>Leukocytes--immunology<br/>Lymphocyte Activation<br/>Mice<br/>Mice, SCID<br/>Neutralization Tests<br/>Protein Precursors--genetics<br/>Recombinant Proteins--immunology<br/>T-Lymphocytes--immunology<br/>Vaccines, Synthetic--immunology<br/>Vaccinia virus--immunology<br/>Virus Replication